Principles about financial and other support

We believe that financial support should encompass a variety of sources, including

  • private donors,
  • corporate supporters (from all sectors),
  • conventional health and science support trusts,
  • research and health promotion trusts and
  • international and other organisations focussing on public health, stigma of mental illness and mental health education on a wider scale.

We do not and will not associate Equilibrium with any one pharmaceutical company in particular, nor will Equilibrium associate itself with the promotion or endorsement of any specific drug treatment or other form of commercially available treatment.

Equilibrium strongly supports the principle of ‘Evidence Based Treatment’.  This involves making treatment decisions based on the independent assimilation and evaluation of the available evidence for and against individual and combination treatments. Such information needs to be made available not only for professionals, but also in a form suitable for all. We also believe that more treatment studies should be carried out out with the framework of the pharmaceutical industry.  To use the UK as an example, the Association of the British Pharmaceutical Industry (ABPI) is well aware of the potential for conflicts of interest between industry and clinicians / voluntary sector organisations.  It, therefore, has a strict code of practice which has recently been tightened up. This includes the area of donations to charitable organisations.

We are in the process of developing a clear policy regarding ‘unrestricted grants and donations’ which legally assures our absolute right to independence from any contributors in industry.

Sources of support during start-up period

Financial and significant pro-bono work contributions:

Private individuals

  • Individual private donors
  • Online donations

Corporate support

  • Pharmaceutical Sector:
    • Organon UK
    • Eli Lilly
    • Pfizer
    • Merck, Sharpe and Dohme
  • Non-Pharmaceutical Sector:
    • Decherts LLP (International Law firm)
    • Minervation Ltd (Information technology)
    • Giraffe Ltd
  • Other:
    • University of Oxford
    • University College- University of London